CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. (Q47390442)
Jump to navigation
Jump to search
scientific article published in November 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. |
scientific article published in November 2003 |
Statements
CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling (English)
Asma Gati
Nadia Guerra
Catherine Gaudin
Sylvie Da Rocha
Yann Lécluse
Anne Caignard
Bernard Escudier
1 November 2003